| Dr Rajden E Kutelia, MD | |
|
600 Gresham Dr Fl 5, Norfolk, VA 23507-1904 | |
| (757) 388-3198 | |
| (757) 388-4242 |
| Full Name | Dr Rajden E Kutelia |
|---|---|
| Gender | Male |
| Speciality | Internal Medicine |
| Experience | 27 Years |
| Location | 600 Gresham Dr Fl 5, Norfolk, Virginia |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1013993906 | NPI | - | NPPES |
| 8399297 | Medicaid | WA |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207R00000X | Internal Medicine | 43232 (Washington) | Secondary |
| 208M00000X | Hospitalist | 0101253361 (Virginia) | Secondary |
| 207R00000X | Internal Medicine | 0101253361 (Virginia) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Sentara Norfolk General Hospital | Norfolk, VA | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Ivyrehab Sept, Llc | 7911990908 | 1137 |
| Sentara Medical Group | 8921903923 | 1058 |
News Archive
Researchers from Massachusetts Eye and Ear/Harvard Medical School have identified inflammatory factors that cause optic neuropathy in the back of the eye following implantation of a keratoprosthesis (KPro) — similar to what glaucoma patients experience, without the rise of pressure in the eye — and have shown that blocking one of those factors, tumor necrosis factor alpha (TNFa), successfully halts the development of optic nerve damage in a mouse model.
Enterotoxigenic Escherichia coli (ETEC) bacteria are responsible each year for around 400 million cases of diarrhoea and 400,000 deaths in the world's low- and middle-income countries. Children under the age of five are most affected.
According to the U.S. Centers for Disease Control and Prevention, colorectal cancer is the second leading cause of cancer death in the United States. However, according to Mark Pochapin, MD, the Sholtz/Leeds professor of Gastroenterology and director of the Division of Gastroenterology at NYU Langone Medical Center : "With early screening and prevention, this is one cancer that is highly curable and often preventable."
Cardiovascular Systems, Inc., announces the first patient enrollment in its prospective, randomized CALCIUM 360° clinical trial, part of the company's 360° Clinical Series. The CALCIUM 360° study will evaluate the treatment of peripheral arterial disease (PAD) behind and below the knee using CSI's Diamondback 360® PAD System, a minimally invasive catheter for treating PAD anywhere in the leg.
› Verified 1 days ago
| Entity Name | Sentara Medical Group |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1265485270 PECOS PAC ID: 8921903923 Enrollment ID: O20031203000466 |
News Archive
Researchers from Massachusetts Eye and Ear/Harvard Medical School have identified inflammatory factors that cause optic neuropathy in the back of the eye following implantation of a keratoprosthesis (KPro) — similar to what glaucoma patients experience, without the rise of pressure in the eye — and have shown that blocking one of those factors, tumor necrosis factor alpha (TNFa), successfully halts the development of optic nerve damage in a mouse model.
Enterotoxigenic Escherichia coli (ETEC) bacteria are responsible each year for around 400 million cases of diarrhoea and 400,000 deaths in the world's low- and middle-income countries. Children under the age of five are most affected.
According to the U.S. Centers for Disease Control and Prevention, colorectal cancer is the second leading cause of cancer death in the United States. However, according to Mark Pochapin, MD, the Sholtz/Leeds professor of Gastroenterology and director of the Division of Gastroenterology at NYU Langone Medical Center : "With early screening and prevention, this is one cancer that is highly curable and often preventable."
Cardiovascular Systems, Inc., announces the first patient enrollment in its prospective, randomized CALCIUM 360° clinical trial, part of the company's 360° Clinical Series. The CALCIUM 360° study will evaluate the treatment of peripheral arterial disease (PAD) behind and below the knee using CSI's Diamondback 360® PAD System, a minimally invasive catheter for treating PAD anywhere in the leg.
› Verified 1 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Rajden E Kutelia, MD 600 Gresham Dr Fl 5, Norfolk, VA 23507-1904 Ph: (757) 388-3198 | Dr Rajden E Kutelia, MD 600 Gresham Dr Fl 5, Norfolk, VA 23507-1904 Ph: (757) 388-3198 |
News Archive
Researchers from Massachusetts Eye and Ear/Harvard Medical School have identified inflammatory factors that cause optic neuropathy in the back of the eye following implantation of a keratoprosthesis (KPro) — similar to what glaucoma patients experience, without the rise of pressure in the eye — and have shown that blocking one of those factors, tumor necrosis factor alpha (TNFa), successfully halts the development of optic nerve damage in a mouse model.
Enterotoxigenic Escherichia coli (ETEC) bacteria are responsible each year for around 400 million cases of diarrhoea and 400,000 deaths in the world's low- and middle-income countries. Children under the age of five are most affected.
According to the U.S. Centers for Disease Control and Prevention, colorectal cancer is the second leading cause of cancer death in the United States. However, according to Mark Pochapin, MD, the Sholtz/Leeds professor of Gastroenterology and director of the Division of Gastroenterology at NYU Langone Medical Center : "With early screening and prevention, this is one cancer that is highly curable and often preventable."
Cardiovascular Systems, Inc., announces the first patient enrollment in its prospective, randomized CALCIUM 360° clinical trial, part of the company's 360° Clinical Series. The CALCIUM 360° study will evaluate the treatment of peripheral arterial disease (PAD) behind and below the knee using CSI's Diamondback 360® PAD System, a minimally invasive catheter for treating PAD anywhere in the leg.
› Verified 1 days ago
Ranjana Neelanjana Mitra, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 830 Kempsville Rd Fl 1, Norfolk, VA 23502 Phone: 757-261-8070 | |
Arunava Paul, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 830 Kempsville Rd, Norfolk, VA 23502 Phone: 757-967-8622 Fax: 757-686-0541 | |
Abbas Asgher Ali, M.D. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 600 Gresham Dr, Ste B, Norfolk, VA 23507 Phone: 757-388-3198 Fax: 757-388-4242 | |
Peter B Laplace, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 426 E Freemason St, Norfolk, VA 23510 Phone: 757-623-6072 Fax: 757-623-9748 | |
Dr. Dace Auzins, M.D. Internal Medicine Medicare: Not Enrolled in Medicare Practice Location: 6316 Richmond Cres, Norfolk, VA 23508 Phone: 757-423-8560 | |
Dr. John S Carrick, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 850 Kempsville Rd, 1st Fl, Norfolk, VA 23502 Phone: 757-261-5283 Fax: 757-261-5849 |